Cargando…
Antithrombotic prophylaxis in a patient with nephrotic syndrome and congenital protein S deficiency
BACKGROUND: Nephrotic syndrome confers an acquired prothrombotic phenotype due to the urinary loss of anticoagulant proteins.Patients with reactivation of nephrotic syndrome may develop thrombosis. CASE PRESENTATION: We report the case of a life-threatening cerebral venous thrombosis in a 13 year-ol...
Autores principales: | Artoni, Andrea, Passamonti, Serena Maria, Edefonti, Alberto, Gianniello, Francesca, Civelli, Vittorio, Martinelli, Ida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770702/ https://www.ncbi.nlm.nih.gov/pubmed/26928822 http://dx.doi.org/10.1186/s13052-016-0227-x |
Ejemplares similares
-
Where do we stand with antithrombotic prophylaxis in patients with COVID-19?
por: Ciavarella, Alessandro, et al.
Publicado: (2020) -
Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio as Risk Factors for Venous Thrombosis
por: Artoni, Andrea, et al.
Publicado: (2017) -
Congenital nephrotic syndrome
por: Jalanko, Hannu
Publicado: (2007) -
Antithrombotic Prophylaxis in the Middle East
por: Arnaout, Samir, et al.
Publicado: (2011) -
Congenital Nephrotic Syndrome – Finish Type
por: Spahiu, Lidvana, et al.
Publicado: (2016)